Sign in
4

Changes in Ownership

Kalaris Therapeutics, Inc. Filed Acc 0000950170-24-085669

Chief Executive Officer sold 9,731 shares at $0.75 ($7,299)

From the SEC's structured data for this filing

Trades in this filing

Brainard Diana · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-07-19 Sale : show line 1 in the form −9,731 $0.75 $7,299 773,251 D
Open-market sales · 9,731 sh · avg $0.75 · $7,299
Loading xslF345X05/ownership.xml…